期刊文献+

氟喹诺酮类和大环内酯类药物对解脲脲原体的抗菌活性分析 被引量:1

In Vitro Antibacterial Activities of Fluoroquinolones and Macrolides Against Ureaplasma urealyticumin
原文传递
导出
摘要 目的研究解脲脲原体(Uu)对氟喹诺酮类和大环内酯类药物的敏感性,及不同pH值对大环内酯类药物在体外抗Uu最低抑菌浓度(MIC)的影响。方法采用微量肉汤法检测了7种抗菌药物对72株Uu的MIC,及在pH值为6.0、6.5和6.9时,4种大环内脂药物抗Uu的MIC50。结果72株Uu对左氧氟沙星、红霉素和罗红霉素耐药率分别为4.2%、15.3%和2.7%,未发现对加替沙星、司帕沙星、阿奇霉素和交沙霉素的耐药。司帕沙星和交沙霉素抗Uu活性最强,而红霉素和罗红霉素的抗Uu活性最差。当pH值6.0升到6.9时,红霉素的MIC50下降8倍,而罗红霉素、阿奇霉素和交沙霉素MIC50分别下降4倍、16倍、8倍。结论Uu对左氧氟沙星、红霉素和罗红霉素存在不同程度的耐药。左氧氟沙星、加替沙星、司帕沙星抗Uu活性依次增强,大环内脂类药物抗Uu活性由强到弱分别是交沙霉素(16环)、阿奇霉素(15环)、红霉素和罗红霉素(14环)。随着pH值在6.0~6.9升高时,大环内脂药物对Uu的MIC随着pH的升高而减少。 Objective To determine the susceptibilities of clinical Ureaplasma urealyticum(Uu)isolates to fluoroquinolo- nes and macrolides, and to explore the effects of medium pH on MIC of macrolides against Uu in vitro. Methods Seven antimicrobial MICs against 72 strains of Uu, and MICs0 of four macrolides in pH at 6.0, 6.5 and 6.9 were assessed by broth microdilution method. Results The resistant rates of 72 strains of Uu were: levofloxacin 4.2%, erythromycin 15.3 %, rox- ithromycin 2.7%, while jatifloxacin, sparfloxacin, azithromycin, and josamycin showed no resistance to them. Among the seven agents, josamycin and sparfloxacin were the most active. When pH increased from 6.0 to 6.9, the MIC50 of erythromycin, roxithromycin, azithromycin and josamycin decreased significantly by 8, 4, 16and 8 respectively. Conclusions The degree of resistance rate of Uu to levofloxacin, rythromycin and roxithromycin varied. New fluoroquinolones such as sparfloxacin and jatifloxacin show greater activity against Uu than levofloxacin; the 16- membered macrolides such as josamycin are more active against Uu than 15 - membered macrolides (azithromycin) and 14 - membered macrolides (erythromycin and roxithromycin). Moreover; the results suggest that the MICs of macrolides to Uu decrease significantly as the culture medium pH increases from 6.0 to 6.9.
出处 《实用预防医学》 CAS 2008年第5期1560-1562,共3页 Practical Preventive Medicine
关键词 解脲脲原体 大环内脂类药物 喹诺酮类药物 最低抑菌浓度 Ureaplasma urealyticum Macrolides Fluoroquinolones MIC
  • 相关文献

参考文献8

  • 1Y - H Li, Z- QYan, J Skov Jensen, et al. Activation of nuclear factor NF-κB and induction of indu - cible nitric oxide synthase by ureaplasma urealyticum in macrophages[J]. Infect Immun, 2000,68 : 7087- 7093.
  • 2吴移谋,宋颖.泌尿生殖道支原体感染的实验室诊断研究[J].中华医学检验杂志,1991,14(3):157-159. 被引量:33
  • 3National committee for clinical laboratory standards. Performance standards for antimierobialsusceptibility testing; twelfth informational supplement. M100 - S12 [ Z]. Pennsylvania: NCCLS, 2002,1 - 33.
  • 4Roberts MC, Kenny GE. Dissemination of the teM tetracycline resistance determinant ureaplasma urealytieum [ J ]. Antimicrob agents chemother, 1986,29 : 350 - 352.
  • 5Bebear CM, Renaudirl H, Charron A, et al. In vitro activity of trovaflox- acin compared to those of five antimicrobials against mycoplasmas including mycroplasma hominis and ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized [ J ]. Antimicrob Agents Chemother,2000,44:2557- 2560.
  • 6Chamney WS,Tober CL. Superiority of 11,12 carbonate macrolide antibiotics as inhibitors of translation and 50S ribosomal subunit formation in staphylococcus aureus cells[ J ]. Curr Microbiol, 1999,38 ( 6 ) : 342 - 348.
  • 7Kenny GE, Cartwright FD. Susceptibility of macroplasma hominis, M pneumoniae, and ureaplasma urealytieum to GAR - 936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, lindz - olid, moxifloxaein, quinupristin- dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyelines and quinolones [J]. Antimicro bial agents chemother, 2001,45 : 2604 - 2608.
  • 8夏志扬,杨飞兰,钱进霞,刘海燕,王燕玲.244例解脲和人型支原体浓度及药敏分析[J].中国性病艾滋病防治,2002,8(5):282-283. 被引量:8

二级参考文献3

  • 1Drlicak, zhao X. DNA gyrase, topoisomerase Ⅳ, and the 4 -quinolones. Mierobiol MOL Rev, 1997, 61 (3) : 377 - 392
  • 2Kong FR, Zhu, Xj, Wang WZ, et al, Comparative, analysis and serovar-specific identification, of multple - banded antigen, genes of ureaplasma urealyticum biovar one. J Clin Microbiol, 1999, 37(3) : 538 - 543
  • 3张文波,吴移谋,尹卫国,余敏君.解脲脲原体拓扑异构酶基因突变与耐喹诺酮类药物关系的研究[J].中华检验医学杂志,2001,24(6):346-349. 被引量:38

共引文献39

同被引文献23

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部